Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Simple cube puzzle could help doctors gauge brain function at bedside

NCT ID NCT07484048

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tested a simpler version of a cube-building puzzle to see if it can be used at a patient's bedside to assess planning and problem-solving skills. Researchers worked with 30 healthy volunteers to identify any practical issues with the new test. The goal is to develop a quick, easy tool for doctors to evaluate thinking abilities in people with brain injuries or other neurological conditions.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

What this could lead to
If successful, this could lead to a practical bedside test that helps doctors quickly assess a patient's ability to plan and solve problems after a brain injury or stroke.
What could go wrong
This is a very early feasibility study with only 30 healthy volunteers, not patients. The test may not work well in real hospital settings or provide useful information for clinical decisions.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

30 people

The number who actually took part.

Started

Sep 2025

Finished

Apr 2026

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 years and older

Sex

Anyone

Healthy volunteers

Accepted

You do not need to have the condition being studied to take part.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria for the main (non-neuropsychologist) element include: * General population. For convenience at this feasibility study stage this will be largely comprised of colleagues working with GHT, above the age of 18, with no upper age limit. * Have given informed consent having followed the procedure in the protocol * Have the physical/sensory abilities to undertake the test procedures (e.g. use of both hands, adequate vision) * Sufficient English language to be able to follow test instructions Exclusion criteria for the main (non-neuropsychologist) element include: * Under the age of 18 * Refusal/inability to give informed consent * Insufficient English language to be able to follow test instructions * Using cognitive testing as part of their clinical work, or ongoing familiarity with cognitive tests. * Working directly with the main investigator. * Presence of a self-reported cognitive difficulty/neurological condition - not because that in itself would be problematic for test administration or for the information generated, but rather to avoid potential distress to participants were they to find the tests administered challenging. * Presence of any physical/sensory/cognitive difficulty that would confound administration of the tasks, e.g. being partially sighted or having use of only one upper limb * There are no exclusion criteria based on gender identity, ethnicity or handedness. * There are no exclusion criteria relating to medication. Inclusion criteria for the PPI (neuropsychologist) element include: * clinical psychologists in GHT who have or have had a role that involves the administration of cognitive tests * Have given informed consent having followed the procedure in the protocol * Have the physical/sensory abilities to undertake the test procedures (e.g. use of both hands, adequate vision) * Sufficient English language to be able to follow test instructions Exclusion criteria for the PPI (neuropsychologist) element include: * Under the age of 18 * Refusal/inability to give informed consent * Insufficient English language to be able to follow test instructions * Presence of a self-reported cognitive difficulty/neurological condition - not because that in itself would be problematic for test administration or for the information generated, but rather to avoid potential distress to participants were they to find the tests administered challenging. * Presence of any physical/sensory/cognitive difficulty that would confound administration of the tasks, e.g. being partially sighted or having use of only one upper limb * There are no exclusion criteria based on gender identity, ethnicity or handedness. * There are no exclusion criteria relating to medication.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coginitive assessment are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Cognitive Dysfunction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Cheltenham General Hospital

    Cheltenham, Gloucestershire, GL53 7AN, United Kingdom

  • Gloucestershire Royal Hospital

    Gloucester, Gloucestershire, GL1 3NN, United Kingdom

More trials for these conditions

Other studies related to the condition(s) this trial covers.